1. Home
  2. NKTX vs IMMR Comparison

NKTX vs IMMR Comparison

Compare NKTX & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

N/A

Current Price

$2.95

Market Cap

198.2M

Sector

Health Care

ML Signal

N/A

Logo Immersion Corporation

IMMR

Immersion Corporation

N/A

Current Price

$7.15

Market Cap

215.8M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
NKTX
IMMR
Founded
2015
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
215.8M
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
NKTX
IMMR
Price
$2.95
$7.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$11.33
$13.50
AVG Volume (30 Days)
548.9K
326.5K
Earning Date
05-11-2026
04-13-2026
Dividend Yield
N/A
5.11%
EPS Growth
11.88
N/A
EPS
N/A
0.17
Revenue
N/A
$35,013,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$51.07
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$5.25
52 Week High
$3.72
$8.05

Technical Indicators

Market Signals
Indicator
NKTX
IMMR
Relative Strength Index (RSI) 56.10 40.52
Support Level $2.59 $6.30
Resistance Level $3.29 $7.82
Average True Range (ATR) 0.19 0.19
MACD 0.01 -0.07
Stochastic Oscillator 39.13 7.41

Price Performance

Historical Comparison
NKTX
IMMR

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

Share on Social Networks: